Literature DB >> 8049074

Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection.

A Vecchiarelli1, M Dottorini, D Pietrella, C Monari, C Retini, T Todisco, F Bistoni.   

Abstract

The contribution of human alveolar macrophages (AM) from normal subjects in Cryptococcus neoformans infection was investigated. AM were able to efficiently phagocytize the fungus after opsonization, but killing activity did not occur at an effector-to-target ratio of 10:1 in a 6-h incubation since there was an inhibition of phagosome-lysosome fusion. Moreover, the role of AM as antigen-presenting cells was investigated. Cryptococcus-laden AM were co-cultured with autologous T lymphocytes and lymphoproliferation was determined; a massive blastogenic response of alpha/beta TCR-bearing T lymphocytes was observed. The response started after 1 day of co-culture and was triggered and regulated by IL-1 produced by AM in response to C. neoformans. Finally, the antigen-presentation process was associated with HLA class II DR molecules. This finding suggests that AM play a key role in the lung as antigen-presenting cells and, through the secretion of IL-1, regulate proliferation and activation of T lymphocytes, which are important in mediating pulmonary clearance. We speculate that in immunodepressive conditions, the impairment of AM functions could contribute to the spread of C. neoformans infection from the lung.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8049074     DOI: 10.1165/ajrcmb.11.2.8049074

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  41 in total

1.  Dysregulation in IL-12 secretion by neutrophils from HIV-infected patients.

Authors:  A Vecchiarelli; C Monari; B Palazzetti; F Bistoni; A Casadevall
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Fungal pathogen recognition by scavenger receptors in nematodes and mammals.

Authors:  Terry K Means
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

3.  Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.

Authors:  A Vecchiarelli; C Retini; C Monari; C Tascini; F Bistoni; T R Kozel
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins.

Authors:  L Pitzurra; R Cherniak; M Giammarioli; S Perito; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Jatin M Vyas; Stuart M Levitz
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Macrophage mitochondrial and stress response to ingestion of Cryptococcus neoformans.

Authors:  Carolina Coelho; Ana Camila Oliveira Souza; Lorena da Silveira Derengowski; Carlos de Leon-Rodriguez; Bo Wang; Rosiris Leon-Rivera; Anamelia Lorenzetti Bocca; Teresa Gonçalves; Arturo Casadevall
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

Review 7.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

8.  Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model.

Authors:  M R Gyetko; G H Chen; R A McDonald; R Goodman; G B Huffnagle; C C Wilkinson; J A Fuller; G B Toews
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

9.  Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.

Authors:  C Retini; T R Kozel; D Pietrella; C Monari; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

10.  Differential activation of peritoneal cells by subcutaneous treatment of rats with cryptococcal antigens.

Authors:  José L Baronetti; Laura S Chiapello; Ana P Garro; Diana T Masih
Journal:  Clin Vaccine Immunol       Date:  2009-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.